• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biota Pharmaceuticals Inc

+ Add to Watchlist

NB1:GR

2.345 EUR 0.108 4.40%

As of 07:27:51 ET on 08/01/2014.

Snapshot for Biota Pharmaceuticals Inc (NB1)

Open: 2.362 Day's Range: 0.000 - 2.442 Volume: 300
Previous Close: 2.453 52wk Range: 1.668 - 5.064 1-Yr Rtn: -22.40%

Stock Chart for NB1

No chart data available.
  • NB1:GR 2.345
  • 1D
  • 1M
  • 1Y
2.453
Interactive NB1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NB1

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) -0.2200
Est. PEG Ratio -
Market Cap (M EUR) 86.09
Shares Outstanding (M) 35.10
30 Day Average Volume 217
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 6.6480
Dividend Ex-Date 11/09/2012
5 Year Dividend Growth -
Next Earnings Announcement 09/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NB1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NB1

Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.

Russell H PlumbPresident/CEOPeter AzzarelloChief Accounting Officer
Joseph M PattiExec VP:Development & Strategy
More Company Profile & Key Executives for NB1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil